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Abstract 
Background 
Blood vessels form either when dispersed endothelial cells (the cells lining the inner walls of fully-
formed blood vessels) organize into a vessel network (vasculogenesis), or by sprouting or splitting 
of existing blood vessels (angiogenesis). Although they are closely related biologically, no current 
model explains both phenomena with a single biophysical mechanism. Most computational models 
describe sprouting at the level of the blood vessel, ignoring how cell behavior drives branch 
splitting during sprouting.  
Methodology/principal findings 
We present a cell-based, Glazier-Graner-Hogeweg-model simulation of the initial patterning before 
the vascular cords form lumens, based on plausible behaviors of endothelial cells. The endothelial 
cells secrete a chemoattractant, which attracts other endothelial cells. As in the classic Keller-Segel 
model, chemotaxis by itself causes cells to aggregate into isolated clusters. However, including 
experimentally-observed adhesion-driven contact inhibition of chemotaxis in the simulation causes 
randomly-distributed cells to organize into networks and cell aggregates to sprout, reproducing 
aspects of both de novo and sprouting blood-vessel growth. We discuss two branching instabilities 
responsible for our results. Cells at the surfaces of cell clusters attempting to migrate to the centers 
of the clusters produce a buckling instability. In a model variant that eliminates the surface-normal 
force, a dissipative mechanism drives sprouting, with the secreted chemical acting both as a 
chemoattractant and as an inhibitor of pseudopod extension. Both mechanisms would also apply if 
force transmission through the extracellular matrix rather than chemical signaling mediated cell-cell 
interactions.  
Conclusions/significance 
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The branching instabilities responsible for our results, which result from contact inhibition of 
chemotaxis, are both generic developmental mechanisms and interesting examples of unusual 
patterning instabilities.  
PACS: 87.18.Hf; 87.18.Bb; 87.17.Jj; 89.75.Kd; 61.43.Hv 
Keywords: vasculogenesis; angiogenesis; contact inhibition; VE-cadherin; endothelial cells; 
Cellular Potts Model  
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Synopsis 
During embryonic development, endothelial cells (the cells lining the inner walls of blood vessels) 
initially self-organize into a network of solid cords via vasculogenesis. This primary vascular 
plexus then develops into capillaries as the cords hollow out (form lumens) by a variety of 
mechanisms. Further remodeling and association with additional cell types leads finally to the 
mature vascular network. In adults, the vascular network continues to expand by splitting of 
existing blood vessels and by sprouting. Such angiogenesis is crucial during tumor growth, 
diabetes-related conditions, and wound healing.  Using a computer simulation, we have captured a 
small set of biologically-plausible cell behaviors that can reproduce the initial self-organization of 
endothelial cells, the sprouting of existing vessels and the immediately subsequent remodeling of 
the resulting networks. Endothelial cells both secrete diffusible chemoattractants and move up 
gradients of those chemicals by extending and retracting small pseudopods. By itself, such 
chemotaxis causes simulated cells to aggregate into large, round clusters. However, endothelial cells 
stop extending pseudopods along a given section of cell membrane as soon as the membrane 
touches the membrane of another endothelial cell (contact inhibition). Adding contact-inhibition to 
our simulations allows vascular cords to form sprouts under a wide range of conditions. We 
conclude by testing experimentally the simulation’s prediction that network development requires 
contact-inhibited chemotaxis.  
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1. Introduction 
1.1 Vasculogenesis and Angiogenesis  
Blood-vessel development is essential for myriad biological phenomena in healthy and diseased 
individuals, including wound healing and tumor growth [1,2]. Blood vessels form either de novo, 
via vasculogenesis or by sprouting or splitting of existing blood vessels via angiogenesis.  
In vasculogenesis, dispersed endothelial cells (ECs; the cells lining the inner walls of fully-
formed blood vessels) organize into a primary vascular plexus of solid cords which then remodel 
into a vascular network. ECs elongate parallel to the cords, with final aspect ratios of tens to one. 
Because the early stages of vasculogenesis depend on a single cell type, vasculogenesis is relatively 
easy to reproduce in vitro. When cultured in vitro on Matrigel, a commercial product mimicking the 
extracellular matrix (ECM; the mixture of proteins, growth-factors and carbohydrates surrounding 
cells in vivo), even in the absence of other cell types or positional cues, ECs organize into cords 
which form large-scale, honey-comb like patterns, with cords of ECs surrounding regions devoid of 
ECs. This network slowly reorganizes, with the size of the polygonal, cell-free lacunae, gradually 
increasing. This observation suggests that ECs have autonomous patterning ability, rather than 
following morphogen pre-patterns. 
The sprouting or splitting of existing blood vessels during angiogenesis is more complex. In 
the first step of angiogenesis, a vessel dilates and releases plasma proteins that induce a series of 
changes in EC behavior. The ECs which will form the sprout next detach from each other and from 
the surrounding smooth-muscle cells, destabilizing the vessel. These detached ECs proliferate, 
migrate out of the vessel and organize into a sprout. EC proliferation continues in the sprout and is 
fastest just behind the leading tip cell, which is selected using a lateral-inhibition mechanism 
mediated by Dll4 and Notch1 [3]. Finally, the sprout forms a lumen, secretes a basal lamina and 
associates with pericytes that stabilize the sprout to form a mature new vessel [4].  
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Two fundamental questions concerning vasculogenesis and angiogenesis and their relation 
to each other are: 1) Does blood-vessel formation require external patterning cues (pre-patterns of 
morphogens) to define the precise position of the ECs, or can ECs organize into vascular patterns 
autonomously, with external cues merely initiating and fine-tuning vascular morphogenesis?  2) Do 
vasculogenesis and angiogenesis require the same or different cell behaviors, molecular signals and 
biomechanics?  
 
1.2 Experimental Background 
Despite the biomedical importance of angiogenesis and vasculogenesis, existing experiments are 
sufficiently ambiguous that even the fundamental mechanisms guiding patterning are uncertain. 
Experiments suggest a central role for chemotaxis in both de novo and sprouting blood-vessel 
growth [4-6]. ECs respond to, and often produce, a wide range of chemoattractants and 
chemorepellants, including the many isoforms of vascular-endothelial growth factor A (VEGF-A) 
[6], the chemokine SDF-1 [7,8], which ECs secrete [7], fibroblast growth factor 2 (FGF-2), which 
induces ECs in developing vessels to secrete VEGF [9], Slit-2, which can act either as a 
chemoattractant or a chemorepellant depending on the receptor to which it binds [10], and the 
chemorepelling semaphorins [10].   
Which of these molecules (if any) govern vascular patterning is still unclear. The Torino 
Group (e.g. [11,12]) argued that a VEGF-A was the short-range autocrine chemoattractant that their 
chemotaxis-based blood-vessel-growth model required, since ECs express receptors for VEGF 
(VEGFR-2), chemotax towards sources of VEGF under favorable conditions, and secrete VEGFs. 
However, experiments suggest that cell-autonomous secretion of VEGF is essential only for 
vascular maintenance, not for angiogenesis per se:  mice genetically-engineered to lack the VEGF 
gene only in their ECs have normal vascular density and patterning, but impaired vascular 
homeostasis and EC survival [13]. A plausible, alternative cell-autonomous chemoattractant to 
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guide EC aggregation is the chemokine SDF-1/CXCL12, which ECs both secrete and respond to 
[8]. 
However, based on experiments that suggest that ECs can follow stresses in the ECM (see 
e.g. [14] for review), Manoussaki and Murray [15], and Namy et al. [16] proposed that mechanical 
interactions rather than, or in addition to, chemical interactions govern vasculogenesis. Further 
complicating this picture, Szabo and coworkers [17] showed that non-vascular, glia or muscle cells 
cultured on rigid, plastic culture dishes in continuously-shaken medium can form linear structures. 
Such culture conditions should reduce both the formation of chemoattractant gradients or migration 
along stress lines in the ECM. In the absence of ECM, they hypothesized that cells preferentially 
move towards elongated structures. Szabo and coworkers [17] proposed two mechanisms for such 
cell behavior: cells would align to surrounding cells, or they would mechanotactically follow stress 
fields in the cytoskeleton of neighboring cells. However, the molecular mechanisms of such cell 
behavior remains unclear as is the relevance of these results to ECs.  
Angiogenesis and vasculogenesis also require a number of local, contact-dependent 
(juxtracrine) signals: Tip-cell selection during angiogenic sprouting depends on Delta-notch 
signaling [3], while Eph receptor-ephrin ligand binding amplifies ECs’ response to SDF-1 [8]. All 
ECs express vascular-endothelial-cadherin (VE-cadherin), a homophilic, trans-membrane cell-
adhesion molecule, which appears to play a crucial role in vascular patterning [18,19]. Besides its 
role in cell-cell adhesion, VE-cadherin has a signaling function that determines how ECs respond to 
VEGF-A. When ECs bind to other ECs through their VE-cadherin, VEGF-A reduces their motility 
and proliferation. In the absence of VE-cadherin binding, VEGF-A activates pathways related to 
actin polymerization and the cell cycle, enhancing cell motility and proliferation in sub-confluent 
monolayers, and causes preferential extension of pseudopods in directions with higher VEGF-A 
concentrations [20]. We hypothesize that VE-cadherin-binding acts locally to prevent extension of 
pseudopods in the direction of cell-cell contacts for all critical chemoattractants, not only to VEGF-
A. VE-cadherin -/-  double-knock-out mice develop abnormal vascular networks in the yolk sac 
Contact-inhibited chemotaxis in de novo and sprouting blood vessel growth 
Roeland Merks et al.   Page 8 30/05/08 
 
[18], with ECs forming isolated vascular islands instead of wild-type polygonal vascular networks. 
These mice also have defective angiogenic sprouting, suggesting that both vasculogenesis and 
angiogenesis require VE-cadherin. VE cadherin -/- ECs still form strong adhesive junctions, so loss 
of VE-cadherin-mediated signaling rather than loss of intercellular adhesion seems to be 
responsible for the knock-out phenotype [18]. 
 
1.3 Computational Background 
Fortunately, a number of models and simulations replicate features of in vitro vascular patterning 
and can help partially reconstruct minimal sets of behaviors ECs require to self-organize into 
polygonal, vascular patterns [11,12,15-17,21-23].   
Because of the experiments we discussed above and others which have demonstrated that 
sprouting angiogenesis and vasculogenesis both require chemotaxis (see, e.g., [7,8,24]), most 
models of vasculogenesis assume that intercellular signaling occurs via a diffusible 
chemoattractant. Using continuum models deriving from the fluid-dynamic Burgers’ equation, 
Preziosi and coworkers (called the Torino Group in this paper) showed that simulated ECs secreting 
a chemoattractant that attracts surrounding ECs, could self-organize into polygonal patterns similar 
to the patterns in EC cultures and in vivo [11,12,25,26]. However, their work assumed that 
endothelial cells accelerate in chemical gradients, which is not plausible in the highly viscous, non-
inertial environment of the ECM. Microfluidic evidence indicates that mammalian cells (HL60) 
rapidly reach a flow-dependent, constant velocity [27] in chemoattractant gradients rather than 
continuously accelerating. We have previously suggested that [22] a linear force-velocity relation is 
the most appropriate model of ECs’ experimental response, with the velocity of ECs proportional to 
the strength of the gradient of the chemoattractant. However, in simulations of this simple model, 
isotropic ECs form well-separated rounded clusters instead of networks. We have shown that 
adding one of a number of mechanisms (including cell adhesion [21] and cell elongation [22]) to 
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chemotactic aggregation suffices to produce quasi-polygonal networks. Section 2 discusses these 
mechanisms in more detail.   
In the mechanical models of Manoussaki and Murray [15], and Namy et al. [16] ECs pull on 
the elastic ECM and aggregate by haptotactically migrating along the resulting ECM stress lines. 
Surprisingly, the mathematical form of the chemical and mechanical models is practically identical. 
Because these mechanical models assume that ECs exert radially-symmetric stresses on the ECM, 
modeling stress fields and EC haptotaxis or EC secretion and response to a chemoattractant, results 
in the same cell movement. Since simulations of the two mechanisms are identical, distinguishing 
between the effects of chemical and mechanical mechanisms will require additional experiments 
(such experiments are currently underway in the Glazier laboratory (Shirinifard, Alileche and 
Glazier, preprint, 2008)).   
 A separate set of simulations address angiogenesis. Many models of sprouting blood-vessel 
growth introduce blood-vessel-level phenomenology by hand through high-level rules for branching 
[28-30]. Attempts to derive blood-vessel sprouting and splitting from the underlying behavior of 
ECs include Levine and coworkers’ [31] model of the onset of angiogenic sprouting as a reinforced 
random walk, where the ECs degrade the ECM, which locally enhances EC motility and produces 
paths of degraded ECM, and Bauer and Jiang’s [32] cell-based model of blood-vessel sprouting 
along externally-generated morphogen gradients, which assumed that branch splitting results from 
ECM inhomogeneities. Neither model can explain both EC assembly and blood-vessel sprouting. 
 Could the behavior of the individual ECs also explain aspects of blood-vessel sprouting? 
Because the same genetic machinery regulates both angiogenesis and vasculogenesis [4], a common 
set of mechanisms is plausible. Manoussaki [33] extended her mechanical model of vasculogenesis 
to describe angiogenesis by adding long-range, chemotactic guidance cues. In her simulations, ECs 
migrated from an aggregate towards a chemoattractant source and cell-traction-driven migration 
contracted the sprout into a narrow, vessel-like cord.  
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In this paper we present an alternative chemotaxis-based mechanism that can produce 
networks both from dispersed ECs and EC clusters without requiring long-range guidance cues. 
Instead, in our model long-range signals would only steer the self-organized vessels, a more 
biologically-realistic mechanism. Extending simulations that we have briefly introduced elsewhere 
[23], we show that VE-cadherin-mediated contact inhibition of chemotactic pseudopod projections, 
in combination with secretion of a diffusing, rapidly decaying chemoattractant by ECs, suffices to 
reproduce aspects of both de novo and sprouting blood-vessel growth. In our simulations ECs: a) 
secrete a chemoattractant and b) preferentially extend pseudopods up gradients of the 
chemoattractant, unless, c) contact inhibition locally prevents chemotactic pseudopod extension. 
Thus, cell-cell binding suppresses the extension of chemotactic pseudopods, while unbound cell 
surfaces in contact with the ECM continue to extend pseudopods towards sources of 
chemoattractant [24]. We compare two biologically-plausible scenarios for chemotaxis, one in 
which ECs actively extend and retract pseudopods along chemoattractant gradients, and one in 
which the pseudopods’ retractions are chemotactically neutral. The second scenario suggests a 
sprouting mechanism where a secreted autocrine factor acts both as a long-range chemoattractant 
and a local inhibitor of pseudopod sprouting. 
2. Results 
We modeled endothelial cell behavior at a mesoscopic level using the Glazier-Graner-Hogeweg 
(GGH) model, also known as the Cellular Potts Model (CPM) [34-37]. The GGH is a lattice-based 
Monte-Carlo approach that describes biological cells as spatially-extended patches of identical 
lattice indices. Intercellular junctions and cell junctions to the ECM determine adhesive (or binding) 
energies. The GGH algorithm, which we describe in more detail in Section 4 (Materials & 
Methods), models pseudopod protrusions by iteratively displacing cell interfaces, with a preference 
for displacements which reduce the local effective energy of the configuration. Cells reorganize to 
favor stronger rather than weaker cell-cell and cell-ECM bonds and shorter rather than longer cell 
Contact-inhibited chemotaxis in de novo and sprouting blood vessel growth 
Roeland Merks et al.   Page 11 30/05/08 
 
boundaries. In addition to interface displacements that reduce the effective energy, active cell 
motility also allows displacements that increase the effective energy. The likelihood of these active 
displacements increases with the cell-motility parameter T. Further constraints regulate cell 
volumes, surface areas, and chemotaxis. To model chemotaxis, we use the Savill and Hogeweg [36] 
algorithm that favors extensions of pseudopods up concentration gradients of a chemoattractant (see 
Eq. 3 in Section 4). In the simplest implementation of chemotaxis in the GGH, cell velocity is 
proportional to the strength of the chemical gradient, in general agreement with experiments; see 
e.g. [22] (we discuss the details of chemotaxis implementation below in the subsections 2.5 and 2.6 
and in Section 4; see especially Eq. 3).  
The advantage of the GGH over alternative cell-based modeling approaches [38] that 
represent cells as point particles or fixed-sized spheres or ellipsoids is that we can differentiate 
between bound and unbound regions of cell membrane. The GGH naturally represents the 
stochastic, exploratory behavior of migrating cells, modeling it as the biased extension and 
retraction of pseudopods, instead of a biologically-implausible single force acting on cells’ centers 
of mass as in some cell-based simulations. 
 We described chemoattractant diffusion and degradation macroscopically, using a 
continuum approximation. In analogy to the Torino Group’s continuum model of de novo blood-
vessel growth [12,25], ECs secrete a diffusing chemoattractant at a rate ! , which degrades in the 
ECM at a rate !  (e.g. due to proteolytic enzymes or by binding to ECM components), obeying:  
 
 
!c
!t
= "(1# $ (% (
!
x),0)) # &$ (% (
!
x),0)c + D'2c,  (1) 
 
where 
 
! (" (
!
x),0) = 0  inside cells and is 
 
! (" (
!
x),0) = 1 in the ECM. Because we wish to compare 
our simulations to experimental yolk-sac cultures, where the vascular patterns are essentially 
monolayers, we use a two-dimensional GGH.  
 
Contact-inhibited chemotaxis in de novo and sprouting blood vessel growth 
Roeland Merks et al.   Page 12 30/05/08 
 
We set the chemoattractant’s secretion rate by cells 3 110 s! " "= , its decay rate ! "= , and its 
diffusion constant in ECM to a slow D = 10
!13
 m
2
s
!1 . These parameter values produce steeper 
gradients than those for VEGF-A
165
, the chemoattractant which Gamba et al. suggested was 
responsible for vasculogenesis, which has a diffusion coefficient of 11 2 110  m sD ! !!  [12]. The 
diffusion coefficient of SDF-1/CXCL12 is in the range of  1.7 !10
"13
 m
2
s
"1[39]. However, the 
phenomena we observe in our simulations hold over a large range of diffusion coefficients. 
 
2.1 EC aggregation and vasculogenesis in the absence of contact inhibition 
In Fig. 1(A-C) and Movie S1, we randomly distributed 1000 ECs, each with an area of 
 
~ 200 !m
2  
over an area of 
 
! 700 !m " 700 !m  ( 333! 333  lattice sites, or pixels,  of  2 !m !  2!m each), which 
we positioned inside a larger lattice of 
 
1000 !m !1000 !m  to minimize boundary effects. In this 
cell-based simulation of the Torino Group’s continuum model [11,12], without endothelial-cell 
acceleration in chemoattractant gradients our cells form disconnected, vascular islands rather than a 
vascular network. We would expect this result, because, with the more realistic chemotactic 
response we employ, the Torino Group’s model reduces to the classic Keller-Segel equations [40] 
of chemotactic aggregation [25], which, like our simulations, form isolated vascular islands. 
Apparently, the basic Torino-Group model of chemotactic cell aggregation misses a biological 
mechanism essential for vasculogenesis. We have previously suggested a number of additional 
mechanisms, any one of which, together with cell aggregation, suffices to induce vasculogenesis-
like patterning. E.g., when we gave the ECs the elongated shapes observed in later stages of 
experiments, neighboring cells aligned with each other, causing cell clusters to elongate and 
interconnect, creating a vascular network, in a mechanism similar to Szabo’s [17]. These vascular 
networks remodel gradually, with dynamics resembling those of in-vitro vascular networks. The 
causes of cell elongation in experiments are not clear. ECs could elongate either cell-autonomously 
(e.g. by remodeling their cytoskeletons), or non-cell-autonomously, by maximizing their contact 
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areas with surrounding cells or by aligning to morphogen gradients in the ECM [22]. Unless we 
state otherwise, in this paper we neglect cell-autonomous elongation. 
Even without strong cell-cell adhesion the ECs can form vascular-like structures in 
simulations of vasculogenesis  if the diffusion length of the chemoattractant (the length L over 
which the concentration drops to half its value at the EC membrane) is short enough, because the 
ECs align with the chemical gradients [23]. This length scale L depends on the diffusion 
coefficientD  and the chemoattractant decay rate ! as L =
D
!
 [12].  
 
2.2 Sprouting angiogenesis in the absence of contact-inhibition 
To investigate whether the Torino-Group Model could reproduce sprouting angiogenesis, we started 
our simulations with rounded clusters of simulated ECs representing a blood vessel’s surface after 
degradation of the ECM,  keeping the simulation parameters unchanged from Fig. 1. As we 
expected, the clusters of ECs did not form sprouts,  Fig. 4(C).  
 As in vasculogenesis, cell-elongation sufficed to drive angiogenesis-like sprouting (see Fig. 
2(G-I)), where we used a length constraint, see [22]). EC clusters also produced sprouts for strong 
cell-cell adhesion (i.e. for values of J(c,c)<10) (Fig. 2(A-C)), via a mechanism similar to the cell-
elongation-dependent mechanism for vasculogenesis [22]. Adhesion-independent sprouting 
occurred only for a narrow range of very small diffusion constants of the chemoattractant, between 
D < 2 !10
"14
m
2
s
-1  and D > 4 !10
"14
 m
2
s
-1
 (see Fig. 2(D-F)). The allowable range of D increased for 
bigger  cells  [23].  
Figs. 7-10 and supplementary Fig. S1 show the results of systematic screens for sprouting in 
the absence of contact-inhibited chemotaxis, but we defer an in-depth study of these phenomena to 
our future work.  
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2.3 Contact-inhibited chemotaxis in de novo blood vessel growth 
In this paper, we focus on the role of contact-inhibited chemotaxis in sprouting blood-vessel 
growth. We hypothesize that VE-cadherin’s local inhibition of chemotaxis-induced pseudopod 
extensions at EC-EC boundaries, may be responsible for ECs’ self-organization into vascular-like 
networks.  
 We modeled contact inhibition of chemotaxis in our simulations by suppressing chemotaxis 
at cell-cell interfaces. Thus, only interfaces between cells and ECM respond to the chemoattractant. 
Fig. 1(D) and Supplementary Movies S2 and S3 show typical simulations of de novo blood-vessel 
growth with contact inhibition. The ECs assemble into a structure resembling a capillary plexus: 
cords of cells enclose lacunae, which grow slowly. Smaller lacunae shrink and disappear, while 
larger lacunae subdivide via vessel sprouting as, e.g., in the quail yolk sac [41]. 
 
2.4 Contact-inhibited chemotaxis in blood vessel sprouting 
To investigate the role of contact-inhibited chemotaxis in blood vessel sprouting, we ran a set of  
simulations with a large cluster of endothelial cells representing a blood vessel’s surface after 
degradation of the ECM, keeping all simulation parameters the same as those in  
The surface of the cluster first roughens, with some cells protruding from the surface, then digitates 
into a structure reminiscent of a primary vascular plexus (Fig. 4 (A-C) and Movies S4 and S5), the 
first type of structure to develop in both de novo and sprouting blood-vessel growth [41]. The 
sprouting instability requires contact inhibition of chemotaxis. Without it, the clusters remained 
rounded and compact (Fig. 4(D)). Thus our simulations suggest that a process operating at the level 
of individual cells—chemotaxis with contact inhibition—may drive in vitro blood-vessel growth 
both sprouting and de novo.  
 What drives blood vessel sprouting in our model? At equilibrium, the chemoattractant has a 
quasi-Gaussian profile across the cluster. It levels off towards the cluster’s center, while its 
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inflection point is at the cluster boundary. Chemotaxis produces a continuous, inward, normal force 
at the cluster boundary, creating a buckling instability (see e.g. [42]); chemotactic forces also 
compress small initial bumps laterally, producing sprouts. Since contact inhibition of chemotaxis 
leaves the interior cells insensitive to the chemoattractant, ingressing surface cells easily push them 
aside. When we omit contact inhibition of motility to mimic anti-VE-cadherin-antibody-treated 
allantois cultures, the interior cells also feel the inward-directed chemotactic forces and resist 
displacement (Fig. 4 (D) and Movie S6).  
 To explore this idea, we varied the ratio of the chemotactic response at cell-cell interfaces 
relative to the chemotactic response at cell-ECM interfaces ( !(c,c) / !(c,M ) ), where  !(c,c) is the 
ECs’ sensitivity to the chemoattractant at cell-cell interfaces and  !(c,M )  the sensitivity at cell-
ECM interfaces (see Section 4 for details). We looked for sprouting in clusters of 128 cells, each of 
area 
 
~ 200 !m
2 , placed in a 
 
400 !m ! 400 !m  lattice, keeping all other parameters unchanged 
from their values in Fig. 4.  
We defined the clusters’ compactness after 10000 Monte Carlo Steps (the time unit of the 
simulation, see Section 4, with 1 MCS equivalent to about 30 s) to be 
cluster hull
C A A= / , the ratio 
between the cluster’s area, 
cluster
A , and the area of its convex hull (that is the tightest possible “gift 
wrapping” around the cluster), 
hull
A . The compactness  C = 1  for a perfectly circular cluster, 
whereas  C! 0  for highly branched or dispersed clusters of cells.  
 We found a phase transition at ( ) ( ) 0 5c c c M! !, / , " .  separating sprouting from non-
sprouting clusters (Fig. 5), suggesting that the sprouting instability only occurs when the core of the 
cluster behaves as a fluid: because each cell’s volume is nearly conserved (apart from small 
fluctuations around its target volume), the core cells can only release the pressure the ingressing 
cells exert on them by moving outwards as sprouts. Our ongoing work characterizes this instability 
mathematically, proving that the cluster self-organizes into a network structure with fixed cord 
width (A. Shirinifard and J. A. Glazier, preprint 2008). 
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To validate our model against published EC tracking experiments [19], we compared the 
trajectories of cells in sprouting and non-sprouting clusters. Fig. 6(A-D) show the trajectories of ten 
cells in a sprouting cluster (with contact-inhibition; panels a-b), and ten cells in a non-sprouting 
cluster (without contact-inhibition; panels c-d). In non-sprouting clusters, cells followed random-
walk trajectories, while in sprouting clusters, they followed biased random-walk trajectories. To 
further characterize cell motility, we measured cells’ average displacements and velocities over 10 
independent simulations of 128 cells each. In sprouting clusters, the cells moved further during a 
given interval than in non-sprouting clusters. Thus, the cell velocity 
  
 
V
i
(t) = (
! 
x 
i
(t + !t) "
! 
x 
i
(t " !t)) /2!t  [19] is larger during sprouting if the interval 
 
!t  between 
subsequent cell positions is sufficiently large (here we use 
 
!t = 2.5 h as in Perryn et al. [19]); for 
shorter intervals (e.g. 30 s) the cell velocity is highest in non-sprouting clusters (not shown), 
indicating that ECs in sprouting clusters moved faster, but had a somewhat slower random motility.  
Our simulations agree with recent experiments tracking ECs in embryonic mouse allantoides 
[19] that measured the cell-autonomous motility of ECs cells in allantoides relative to the motility 
of the surrounding mesothelium in which the ECs reside. Administration of anti-VE-cadherin 
antibodies reduced both cell-autonomous motion and net displacement of ECs. Thus, our 
simulations suggest that VE-cadherin’s role as a contact-dependent inhibitor of cell motility suffices 
to explain the reduced cell motility observed in anti-VE-cadherin-treated allantoides cultures. 
 
2.5 Sensitivity analysis 
Contact-inhibited sprouting occurs for a wide range of parameter values. In most of our simulations 
we set the EC-EC adhesion equal to the EC-ECM adhesion (i.e. J(c,c) = 2J(c,M ) ; the factor of 2 
arises because we model the ECM as a single large generalized cell), which is equivalent to setting 
the surface tension of the cluster to zero [35]. Zero surface tension clarifies the role of contact 
inhibition in sprouting, but real ECs adhere strongly to each other via adherens junctions [18]. In 
Fig. 7 and in Movies S7A-P we studied the effect of cell-cell adhesion on sprouting in clusters of 
Contact-inhibited chemotaxis in de novo and sprouting blood vessel growth 
Roeland Merks et al.   Page 17 30/05/08 
 
128 cells (256 cells in the movies). For stronger EC-EC adhesion, equivalent to positive surface 
tension,  J (c,c) < 2J (c, M ) , the sprouts are longer and thinner and the network less compact than 
for zero surface tension.  For very weak EC-EC adhesion (
 
J(c,c)! 2J(c,M ) ), equivalent to strong 
negative surface tension, the ECs separate from each other, so contact-inhibition no longer occurs, 
and the clusters do not sprout. For small negative surface tensions, with values of 
( , ) 2 ( , )J c c J c M> , chemotaxis overcomes the negative surface tension, so ECs still touch each 
other and sprouting occurs as for zero surface tension, producing thickened sprouts and elongated 
clusters. The insets to Fig. 7 and Movies S7N to S7P show the results for 50 ! J(c,c) ! 70 .  
 We also investigated how sprouting depends on the chemotactic strength !(c,M )  (Fig. 8 
and Movies S8A-K).  For !(c,M ) = 500 , most vascular cords are two cells wide (Movie S8B), 
while for !(c,M ) > 500  the cords become thinner and longer, with cords only one cell wide 
(Movies S8C-K). For higher chemotactic forces, the cells intercalate, moving to the chemical 
gradients’ peak. We have derived the conditions for this folding instability in our ongoing work (A. 
Shirinifard and J. A. Glazier, preprint, 2008). Higher chemotactic strengths increase ruffling of the 
cluster boundary, reducing the cluster’s compactness in the absence of contact inhibition (Fig. 8). 
 We assumed that ECs extend or retract pseudopods depending on the difference in 
chemoattractant concentration between the retracted and extended positions, independent of the 
absolute chemoattractant concentrations. However, at higher chemoattractant concentrations, most 
chemoattractant receptors will saturate with chemoattractant and become insensitive to 
chemoattractant levels. To study the effect of saturated chemotactic response [21] on angiogenic 
sprouting, we varied the saturation parameter s (see Eq. 3, Section 4) leaving all other parameters 
unchanged. For s = 0 , the chemotactic response is linear; for s > 0 , the response to the 
chemoattractant gradient vanishes at high concentrations (see Section 4). For small positive s, the 
clusters sprout normally (see Fig. 9 and Movies S9A-C); however, for large s, the chemotactic 
response weakens at the chemoattractant levels present at the edge of the cell cluster; thus cells no 
longer chemotact towards the cluster’s interior and the sprouting instability disappears (Movies 
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S9D-E). We could test this prediction experimentally by partially inactivating the ECs’ 
chemoattractant receptors. We observed the same effect when we increased the chemoattractant 
secretion rate for moderate response saturation (s=0.05; see Supplementary Fig. S2, bottom panel) 
leading to higher overall chemoattractant concentrations. We could test this situation 
experimentally by overexpressing the chemoattractant in ECs. Since for unsaturated chemotactic 
response (s=0), multiplying the chemoattractant concentrations is equivalent to multiplying the 
chemotactic strength ( !(c,M ) ) by the same factor, increasing the secretion rate first thins and 
lengthens the cords by increasing the chemotactic strength, then eventually prevents sprouting as 
the chemotactic response saturates. This effect is most apparent for s = 0.01  (Fig. S2, top panel). 
 In the Torino Group’s continuum model, the separation between the cords increases with  
the diffusion length L of the chemoattractant, Fig. 10 and Movies S10A-G show sprouting clusters 
for a range of diffusion lengths. In agreement with the Torino Group’s model, longer diffusion 
lengths produce thicker cords with larger intercord spaces. The clusters do not sprout well when L 
approaches the EC-cluster diameter. Clusters consisting of 1024 cells sprout for 13 2 13 10  m sD ! !> "  
(
 
L > 17.3 !m ), while 128-cell clusters do not (Fig. 10 and Movies S11A-G). If the diffusion length 
is smaller than the ECs’ diameter, the clusters dissociate: the ECs perform random walks with long 
persistence lengths, moving up the chemoattractant gradients they leave behind themselves (Movies 
S10A and S11A).  
 
2.6 A dissipative sprouting mechanism 
In our simulations, the trailing edges of the ECs retract actively in response to the chemoattractant 
and exert an inward-normal, compressive force on the EC cluster. To check if sprouting requires 
this compressive force, we also simulated a situation in which only extending pseudopods at cell-
ECM interfaces respond to the chemoattractant, while retraction is chemotactically neutral. Both 
sprouting-angiogenesis and vasculogenesis occurred, but required higher intrinsic cell motilities 
(larger values of the parameter T ). Fig. 11 shows the motilities required under both assumptions. 
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We looked for sprouting after 5000 MCS (~ 40 h) in clusters of 128 cells, each of area 
 
! 200 !m
2 , 
placed in a 
 
400 !m ! 400 !m  lattice, with all other parameters the same as in Fig. 4. For 100T < , 
our original chemotaxis assumptions produced sprouts, while no sprouting occurred if pseudopods 
responded to the chemoattractant only during extension. For  100 < T < 400 , both mechanisms 
produced sprouts. For 400T > , the ECs broke up into small pieces, a well-characterized, non-
biological artifact of the GGH [35]. With extension-only chemotaxis, sprouting was slightly slower 
than for standard, extension-retraction Savill-Hogeweg [36] chemotaxis, as a plot of the time 
evolution of the clusters’ compactness shows (Fig. 12 and Movies S12-S14). However, at long 
times ( 2500 MCSt > ) the compactness of clusters decreased at identical rates for both methods.  
 These results suggest an additional mechanism for blood-vessel sprouting: at the cluster 
surface, all pseudopod extensions increase the effective energy slightly, so the chemoattractant 
inhibits pseudopod extension. A recent experimental study [43] found that autocrine secretion of the 
sprouting inhibitor TGF-!1 enhances branching in mammary epithelial tubes. Our model suggests a 
mechanism by which an autocrine, secreted chemical can act both as a chemoattractant and as an 
inhibitor. The rates of pseudopod extensions and retractions are critical to pattern evolution (Fig. 
11). Cells in growing tips see a shallower gradient than do those in valleys between the tips (see e.g. 
Fig. 4(B)), so pseudopod extensions at growing tips are more frequent than in the valleys between 
tips because they have a lower effective-energy cost.  During sprouting, conservation of cell area 
requires that the cells in the valleys must retract, while those in the tips protrude. In the Savill-
Hogeweg algorithm, retraction is energetically favorable, while it is energetically neutral in our 
pseudopod-extension-only chemotaxis algorithm, making the net change in effective energy 
positive with a rate depending on the cell motility. The effective-energy change is negative in the 
Savill-Hogeweg algorithm and thus nearly independent of T  (Fig. 13 where 
0
H  is the initial 
effective energy).  
 
Contact-inhibited chemotaxis in de novo and sprouting blood vessel growth 
Roeland Merks et al.   Page 20 30/05/08 
 
3. Discussion 
We have shown that a single set of cell behaviors, i.e. contact-inhibited chemotaxis to an autocrine, 
secreted chemoattractant can explain aspects of both de novo and sprouting blood-vessel growth. 
Our results suggest that branching in aggregates of chemotacting ECs could result from two 
separate effects of the same mechanism. For low cell motilities T, i.e. a low probability for active, 
dissipative cellular protrusion, the branching resembles a buckling instability (see e.g. [42]), in 
which the surface cells exert a surface-normal force on the cluster’s inner core. For larger cell 
motilities, the shallower chemoattractant gradients at protrusions make the ECs there more likely to 
extend outward-directed pseudopods than cells in the valleys between the protrusions.  
 While we have adopted the Torino Group’s assumption that ECs chemotax in response to 
gradients of a diffusible, autocrine, secreted chemoattractant [12,25], our simulation also reproduces 
continuum models that assume that ECs stress the ECM [15], which either pulls on the surrounding 
ECs, provides haptotactic cues for active EC migration [16], or both [26]. Because these models 
assume that ECs exert radially-symmetric stresses on the ECM, the underlying mathematical 
descriptions of the chemotactic and haptotactic mechanisms are equivalent. In both cases, contact 
inhibition should still operate and the patterning mechanism we have proposed should still apply, 
with traction or haptotaxis replacing chemotaxis and the mechanical screening length replacing the 
diffusion length. Our simulation may also apply to the formation of linear structures by non-
vascular, glia or muscle cells cultured on rigid, plastic culture dishes in continuously-shaken 
medium [17] in which cells explore their environment using long filopodia, then move towards their 
neighbors by pulling themselves along bound filopodia. Thus, the combination of cell aggregation 
and contact-inhibition that drives patterning in our model, could also occur without chemical 
gradients and even without ECM.  
 Our simulations also allow us to clarify a number of subtleties concerning the interpretation 
of our own and others’ experiments in which blocking VE-cadherin interfered with normal vascular 
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patterning. In our in vitro experiments, anti-VE-cadherin treatment caused ECs to round, in addition 
to its hypothesized effect on contact inhibition, so our experiments cannot rule out the possibility 
that the anti-VE-cadherin treatment inhibited vascular patterning because of its effect on EC shape. 
A further complication is that anti-VE-cadherin treatment could conceivably reduce the adhesion 
between ECs. As we noted above, In VE-cadherin -/- knock-out mice, ECs still form strong 
adhesive junctions [18], suggesting that VE-cadherin is not required for EC-EC binding.  
Our simulations show that the contact-inhibition patterning mechanism operates over a wide 
range of cell-cell adhesions, suggesting that changes in adhesivity are not significant provided that 
contact-inhibition persists, and independent of cell shape[23], suggesting that the shape change is 
not significant. However, we have also shown that strong cell-cell adhesion plus chemotaxis can 
produce vascular-like patterns in simulations [21]. Fortunately, the three vascular patterning 
mechanisms (contact-inhibition, cell-elongation and cell-cell adhesion) have vastly different 
kinetics [22]. Thus time-lapse microscopy experiments [19,44] quantifying the kinetics of capillary-
plexus development (see e.g. [22]), will allow us to definitively distinguish among these three 
patterning mechanisms. Already, we can say that adhesion-driven patterning is so slow and requires 
such strong adhesion that it appears incompatible with the available qualitative data from 
experiments.  
To further test if VE-cadherin-mediated, contact-dependent signaling to VEGF-R2 [20], 
rather than VE-cadherin’s function as a cell-adhesion molecule is responsible for the effects of anti-
VE-cadherin treatment in mouse yolk sacs, we could experimentally block signal transduction from 
VE-cadherin to VEGFR-2, specifically interfering with VE-cadherin’s signaling function, while 
leaving its role as an adhesion molecule intact. A possible target would be CD148, which 
phosphorylates VEGFR2 after VE-cadherin binding [20,45]. Embryonic vascularization and 
angiogenic sprouting are severely deficient in CD148 -/- knock-out mice [45], further supporting 
our hypothesis that VE-cadherin’s contact-dependent intercellular signaling is crucial to 
vasculogenesis and angiogenesis. 
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 Perryn et al. [19] showed that anti-VE-cadherin treatment reduced sprout extension in 
murine allantois cultures by 70%, while it reduced cell-autonomous motility along sprout segments 
by 50 %. Based on these results, they postulated that VE-cadherin is required for the motility of 
ECs along sprouts towards the tip. However, our simulations show that the observed cell slow-
down after anti-VE-cadherin administration may be an indirect effect of a reduction of sprouting. 
Furthermore, our simulations suggest that even substantially reduced cell motility may not prevent 
patterning, though it does slow it down. 
 In our simulations, branching and pattern formation require only experimentally-observed 
cell-level mechanisms, instead of the blood-vessel-level phenomenology in some other 
angiogenesis models [28-30].  However, by starting with a cluster of endothelial cells, our 
simulations ignore many events preceding sprout formation, including the release of plasma 
proteins by the vessel, the breakdown of the basal lamina, the detachment of the ECs from 
surrounding ECs and smooth muscle cells, and cell proliferation. They also ignore subsequent 
processes consolidating outgrowth of the sprout, including tip-cell selection, any long-range 
chemoattractants and chemorepellants that guide the vessel to its target, the formation of new basal 
lamina, the sprout’s association with stabilizing cells including pericytes, lumen formation within 
the sprout, and flow-induced remodeling of the developed vasculature. The mechanism for 
sprouting and network formation we have proposed forms a firm basis for future, more complete 
models of angiogenesis which include basal lamina and pericytes. We are currently studying the 
formation of directed sprouts with proliferating ECs in response to additional chemoattractants or 
chemorepellants and analyzing the role of cell elongation during sprouting. We are also studying 
the effect of additional, cell-cell contact-dependent signaling mechanisms, including delta-notch 
tip-cell selection [3] and chemoattractant-response amplifying Eph receptor-ephrin ligand 
interactions [8]. 
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4. Materials and Methods 
4.1. The Glazier-Graner-Hogeweg (GGH) Model 
The GGH represents biological cells as patches of identical lattice indices ( )x!
!
 on a square or 
triangular lattice, where each index uniquely identifies, or labels a single biological cell. 
Connections (links) between neighboring lattice sites of unlike index ( ) ( )x x! ! "#
! !
 represent bonds 
between apposing cell membranes, where the bond energy is ( ( ) ( ))J x x! ! ",
! !
, assuming that the 
types and numbers of adhesive cell-surface proteins determine J . A penalty increasing with the 
cell’s deviation from a designated target volume target ( )A !  imposes a volume constraint on the 
simulated ECs. We define the pattern’s effective energy:  
 
 
 
H =
neighbors
! J (" (
!
x)," (
!
#x ))(1$ % (" (
!
x)," (
!
#x ))) + &
"
! (a(" ) $ Atarget (" ))
2
,  (2) 
 
where x
!
 and x!
!
 are neighboring lattice sites (up to fourth-order neighbors), a  is the current area of 
cell ! , target ( )A !  is its target area, !  represents a cell’s resistance to compression, and the 
Kronecker delta is ( ) {1 0 }x y x y x y! , = , = ; , " . Each lattice site represents an area of 
 
2 !m ! 2 !m . 
Since we assume that ECs do not divide or grow during patterning, we set 
 
A
target
(! ) = 50  lattice 
sites, corresponding to a cell diameter of about 
 
16 !m , and 25! =  for all cells. The ECs reside in a 
very thin layer of extracellular fluid, which is a generalized cell without a volume constraint and 
with 0! = . We assume that the ECs and fluid sit on top of a rigid ECM through which the 
chemoattractant diffuses, but we do not represent this ECM in the GGH lattice. We also assume that 
the presence of the fluid does not disturb the chemoattractant distribution in the ECM. Unless we 
specify otherwise, we use a bond energy ( ) 40J c c, =  between the ECs, and ( ) 20J c M, =  between 
the ECs and the ECM. For these settings the ECs do not adhere without chemotaxis. We define a 
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special, high cell-border energy ( ) 100J c B, =  to prevent ECs from adhering to the lattice 
boundaries. We use fixed boundary conditions.  
 To mimic cytoskeletally-driven pseudopod extensions and retractions, we randomly choose 
a source lattice site x
!
, and attempt to copy its index ( )x!
!
 into a randomly-chosen neighboring 
lattice site x!
!
. For better isotropy we select the source site from the twenty, first- to fourth-nearest 
neighbors [46]. During a Monte Carlo Step (MCS) we carry out N  copy attempts, with N  the 
number of sites in the lattice. We set the experimental time per MCS to 30 s ; for this setting the 
simulated ECs move with nearly their experimental velocity [22]. We calculate how much the 
effective energy would change if we performed the copy, and accept the attempt with probability 
( ) { 0 1 0}
H
TP H e H H
!"
" = ," # ; ," < , where T  defines the intrinsic cell motility. All our simulations, 
except those in Figs. 11-13, use 50T = .  
 In experiments, cells respond to chemoattractant gradients by executing a more-or-less-
strongly biased random walk up or down the gradient, where, over times short enough to allow us to 
neglect adaptation, the velocity of the drift depends on the gradient strength and the absolute 
concentration. We therefore define a set of extensions to the basic GGH model which reproduce 
these empirical behaviors due to preferential extension and retraction of pseudopods up 
chemoattractant gradients [24] by including a chemical effective-energy change at each copy 
attempt [21,36],  
 
 
 
chemotaxis!H = "µ
c(
!
#x )
1+ sc(
!
#x )
"
c(
!
x)
1+ sc(
!
x)
$
%&
'
()
, (3) 
 
where c  is the concentration of the chemoattractant, which we assume is present everywhere in a 
layer of ECM under the ECs, x!
!
 is the target site, x
!
 the source site, and  s  regulates the saturation 
of the chemotactic response. Unless we specify otherwise, we set  s = 0 , in which case chemotaxis 
depends linearly on the chemoattractant gradient only, independent of the chemoattractant 
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concentration. 
 chemotaxis!H
" 0  for large values of s and, for s"0, for high chemical concentrations. 
The chemotaxis coefficient is  µ = !(c,M )  at cell-ECM interfaces and µ = !(c,c)  at cell-cell 
interfaces respectively. Setting ( ) 0c c! , =  and ( ) 500c M! , = ensures that chemotactic extensions 
occur only at cell-ECM interfaces, reflecting VE-cadherin’s suppression of pseudopods. Both 
extending and retracting pseudopods contribute to the chemical effective-energy change. To 
implement pseudopod-extension-only chemotaxis (see Figs. 11-13), where only extending 
pseudopods at the cell-ECM interface respond to the chemoattractant, cells experience a chemical 
effective-energy change only if the source lattice site x
!
 belongs to an EC, i.e.  
 
   
 
chemotaxis!H = "(1" # ($ (
!
x),0))µ(
c(
!
%x )
1+ sc(
!
%x )
"
c(
!
x)
1+ sc(
!
x)
) .                          (4). 
 
For a more detailed discussion of chemotaxis in the GGH model see [47]. We solve the partial-
differential equation for chemoattractant diffusion and degradation (Eq. 1) numerically using a 
finite-difference scheme on a lattice matching the GGH lattice. We use 15 diffusion steps per MCS, 
with 
 
!t = 2 s . For these parameters, the chemoattractant diffuses more rapidly than the ECs, 
enabling us to ignore advection in the medium as the cells push the fluid.  
 Source code for the simulations is available online from 
http://sourceforge.net/projects/tst. Parameter files for the simulations in this 
paper are included in the online supplementary material.  
4.2. Allantois Culture and Immunolabeling 
We dissected allantoides from mouse embryos at embryonic stages 7.5-8.0. We washed the explants 
in fresh, cold ePBS and pipetted them into fibronectin-coated (5 mg/ml ) Delta-T culture dishes 
(Bioptechs, Butler, PA) containing high-glucose, phenol-red-free Dulbecco’s modified Eagles’ 
medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% penicillin-streptomycin, 
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and 1% L-glutamine (GibcoBRL, Grand Island, NY). We maintained the allantoic explants using 
standard culture conditions (37
o
C and 5% CO
2
/ 95% air atmosphere) in a custom-designed culture 
chamber for 12-24 hours in the presence of an endothelial-specific marker, CD34 monoclonal 
antibody (BD PharMingen, San Diego, CA) directly conjugated to Cy3 (Amersham Biosciences). 
We fixed the allantoides in 3% paraformaldehyde for 20 minutes at room temperature, followed by 
an ePBS wash. For VE-cadherin antibody perturbations, we added anti-VE-cadherin monoclonal 
antibody (BD PharMingen, San Diego, CA) at 25  !g / ml  to the culture medium.  
4.3. Image Acquisition 
We observed the cultures with a  10 !  objective (0.30 N.A.) on an inverted, automated, wide-field, 
epifluorescence/differential-interference-contrast (DIC) microscope (Leica DMIRE2, Leica 
Microsystems, Germany). We recorded images (608 ! 512 pixel spatial and 12-bit intensity 
resolution) with a cooled Retiga 1300 camera (QImaging, Burnaby, British Columbia) in 
2 ! 2 binned acquisition mode, using 100-300 ms exposures. Image acquisition and microscope 
settings used software described in [44]. 
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6. Supporting Information 
 
Fig. S1. Compactness (
cluster hull
C A A= / ) of 128-cell clusters after 5000 MCS ( ~ 40 h ) as a function 
of the cell length, in the presence (solid line) or absence (dashed line) of contact inhibition. Lengths 
given in terms of the target length ! as defined in Merks et al. 2006 [22]. Grey lines show standard 
deviations over ten simulations. 
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Fig. S2. Configurations of 128-cell clusters after 5000 MCS ( ~ 40 h ) for increasing 
chemoattractant secretion rates for low (s=0.01) and high (s=0.05) chemoattractant receptor 
saturations. 
6.1 Supporting Movies are available online at 
http://www.psb.ugent.be/~romer/ploscompbiol.  
 
Movie S1. Endothelial cell aggregation without contact-inhibited chemotaxis. Simulation initiated 
with 1000 scattered cells. 0 MCS to 20,000 MCS (~ 0-170 h), 100 MCS per frame.  
 
Movie S2. Endothelial cell aggregation in with contact-inhibited chemotaxis. Simulation initiated 
with 1000 scattered cells. 0 MCS to 2000 MCS (~ 0-20 h), 10 MCS per frame. 
 
Movie S3. Same simulation as Movie S2. 0 MCS to 20,000 MCS (~ 0-170 h), 100 MCS per frame. 
 
Movie S4. Sprouting instability in a simulation with contact-inhibited chemotaxis, initiated with a 
cluster of 256  endothelial cells. 0 MCS to 2000 MCS (~ 0-20 h), 10 MCS per frame. 
 
Movie S5. Same simulation as Movie S4. 0 MCS to 20,000 MCS (~ 0-170 h), 100 MCS per frame. 
 
Movie S6. Simulation with non-contact-inhibited chemotaxis, initiated with a cluster of 256  
endothelial cells. 0 MCS to 2000 MCS (~ 0-20 h), 10 MCS per frame 
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Movies S7A-P. Effect of cell adhesion on sprouting angiogenesis (cf. Fig. 7). Simulations with 
contact-inhibited chemotaxis, initiated with a cluster of 256 endothelial cells. 0 MCS to 20,000 
MCS (~ 0-170 h), 100 MCS per frame. (A) J(c,c)=5; (B) J(c,c)=10; (C) J(c,c)=15; (D) J(c,c)=20; 
(E) J(c,c)=25; (F) J(c,c)=30; (G) J(c,c)=35; (H) J(c,c)=40; (I) J(c,c)=45; (J) J(c,c)=50; (K) 
J(c,c)=55; (L) J(c,c)=60; (M) J(c,c)=65; (N) J(c,c)=70; (O) J(c,c)=75; (P) J(c,c)=80. 
 
Movies S8A-K. Effect of the chemotactic strength on sprouting angiogenesis (cf. Fig. 8). 
Simulations with contact-inhibited chemotaxis, initiated with a cluster of 256 endothelial cells. 0 
MCS to 20,000 MCS (~ 0-170 h), 100 MCS per frame. (A) !(c,M ) = 0 ; (B) !(c,M ) = 500 ; (C) 
!(c,M ) = 1000 ; (D) !(c,M ) = 1500 ; (E) !(c,M ) = 2000 ; (F) !(c,M ) = 2500 ; (G) 
!(c,M ) = 3000 ; (H) !(c,M ) = 3500 ; (I) !(c,M ) = 4000 ; (J) !(c,M ) = 4500 ; (K) 
!(c,M ) = 5000 . 
 
Movies S9A-F. Effect of chemotaxis saturation on sprouting angiogenesis (cf. Fig. 9). Simulations 
with contact-inhibited chemotaxis, initiated with a cluster of 256 endothelial cells. 0 MCS to 20,000 
MCS (~ 0-170 h), 100 MCS per frame. (A) s=0.0; (B) s=0.05; (C) s=0.1; (D) s=0.15; (E) s=0.2; (F) 
s=0.25. 
 
Movies S10A-G. Effect of the diffusion constant D on sprouting angiogenesis (cf. Fig. 10). 
Simulations with contact-inhibited chemotaxis, initiated with a cluster of 256 endothelial cells. 0 
MCS to 20,000 MCS (~ 0-170 h), 100 MCS per frame. (A) D = 1 !10
"14
m
2
s
-1
; (B) 
D = 5 !10
"14
m
2
s
-1
; (C) D = 1 !10
"13
m
2
s
-1
; (D) D = 2 !10
"13
m
2
s
-1
; (E) D = 3 !10
"13
m
2
s
-1
; (F) 
D = 4 !10
"13
m
2
s
-1
; (G) D = 5 !10
"13
m
2
s
-1
. 
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Movies S11A-G. Effect of the diffusion constant D on the proposed sprouting-angiogenesis 
mechanism (cf. Fig. 10). Simulations with contact-inhibited chemotaxis, initiated with a cluster of 
1024 endothelial cells. MCS 0 to 20,000 (~ 0-170 h), 100 MCS per frame. (A) 14 2 11 10 m sD ! != " ; 
(B) 14 2 15 10 m sD ! != " ; (C) 13 2 11 10 m sD ! != " ; (D) 13 2 12 10 m sD ! != " ; (E) 13 2 13 10 m sD ! != " ; (F) 
13 2 1
4 10 m sD
! !
= " ; (G) 13 2 15 10 m sD ! != " . 
 
Movie S12. Sprouting of a 256-cell cluster on a 500 ! 500-pixel lattice (~1 mm !1 mm )with 
standard Savill-Hogeweg, extension-retraction chemotaxis at T=50, as in Fig. 12. 
 
Movie S13. Sprouting of a 256-cell cluster on a 500 ! 500-pixel lattice (~1 mm !1 mm ) with 
standard Savill-Hogeweg, extension-retraction chemotaxis at T=200, as in Fig. 12. 
 
Movie S14. Sprouting of a 256-cell cluster on a 500 ! 500-pixel lattice (~1 mm !1 mm ) with 
extension-only chemotaxis at T=200, as in Fig. 12. 
 
Protocol S1. Tissue Simulation Toolkit v0.1.3. The source code for the software used for the 
simulations presented in this paper is also available from http://sourceforge.net/projects/tst. 
Installation: Unpack and compile according to the instructions given in the INSTALL file. The code 
is written in C++ using the cross-platform (Windows, Mac or Unix/Linux) library Qt (available 
from www.trolltech.com).   
 
Dataset S1. Parameter files for the simulations shown in Figs. 1, 4, 11 and 12, packed as a tar.gz 
archive. To use, unpack the parameter-file archive and install the Tissue Simulation Toolkit 
(Protocol S1). Run the simulations from the command line using the command “vessel [parameter-
file]”. Reproduce the other simulations by editing the parameter files using a standard text editor to 
set the values specified in the text. 
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Figure legends 
 
 
 
Fig. 1. Endothelial cell aggregation; simulation initiated with 1000 scattered cells: (A) After 10 
Monte Carlo steps (MCS) (~ 5 min). (B) After 1000 MCS (~ 8 h). (C) After 10000 MCS (~ 80 h). 
(D) Contact-inhibited chemotaxis drives formation of vascular networks. Scale bar: 50 lattice sites 
(
 
! 100 !m ). Contour lines (green) indicate ten chemoattractant levels relative to the maximum 
concentration in the simulation. Grey shading indicates absolute concentration on a saturating scale. 
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Fig. 2. Sprout formation in the absence of contact inhibition. (A-C) Adhesion-driven sprouting. (A) 
 J (c,c) = 1; (B)  J (c,c) = 5 ; (C)  J (c,c) = 10 ; (D-F) Passive cell elongation at short diffusion 
lengths; (D)  D = 1!10
"14
 m
2
s
-1 ; (E)  D = 2 !10
"14
m
2
s
-1 ; (F)  D = 3 !10
"14
m
2
s
-1 ; (G-I) Cell-
autonomous cell elongation; (G) 
 
! = 22 µm ; (H) 
 
! = 24 !m ; (I) 
 
! = 32 !m . 
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Fig. 3. Anti-VE-cadherin antibody treatment inhibits de novo blood-vessel growth in mouse 
allantois cultures. Endothelial cells fluorescently labeled in red with endothelium-specific CD34-
Cy3 antibody. DIC/fluorescent image overlays. (A-C) Control. (D-F) Anti-VE-cadherin-treated cell 
cultures.  
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Fig. 4. Sprouting instability in a simulation initiated with a cluster of endothelial cells: (A) After 10 
MCS (50 min). (B) After 1000 MCS (~ 8 h). (C) After 10,000 MCS (~ 80 h). (D) No sprouting in a 
simulation without contact inhibition of chemotaxis ( ( ) ( ) 1c c c M! !, / , = ) at 10,000 MCS (~ 80 h). 
Scale bar: 50 lattice sites (
 
! 100 !m ). 
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Fig. 5. Compactness (
cluster hull
C A A= / ) of 128-cell clusters after 10,000 MCS (
 
~ 80 h ) as a function 
of the relative chemotactic response at cell-cell vs. cell-ECM interfaces. Error bars show standard 
deviations over ten simulations. 
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 Fig. 6. Cell trajectories of simulated endothelial cells in 128-cell clusters in a contact-inhibited, 
sprouting cluster (A, B) and in a non-contact-inhibited, non-sprouting cluster (C, D). (A and C) Cell 
trajectories during initial sprouting, indicating the cells’ centers of mass at 100 MCS (~ 50 min) 
intervals from 100 to 5000 MCS (~ 1-40 h). (B and D) Cell trajectories after initial sprouting, 
indicating the cells’ centers of mass at 1000 MCS (~8 h) intervals from 4000 to 20,000 MCS (~ 30-
170 h). Closed circles indicate initial cell positions; open circles indicate final cell positions. Colors 
identify individual cells; brightness increases from dark (initial positions) to bright (final positions).  
Outlines of clusters shown at 1000 MCS (~ 8 h) intervals (a,c) or 4000 MCS (~ 33 h) intervals 
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(b,d). (e) Average displacement of cells from original positions over time in 10 simulations with 
128 cells each, in contact-inhibited (solid curves) and non-contact-inhibited simulations (dashed 
curves). Grey lines indicate standard deviations. (f) Cell velocity 
 
V
i
(t) = (
!
x
i
(t + !t) "
!
x
i
(t " !t)) / 2!t  [19] with  !t = 300 MCS  (~ 2.5 h) for contact-inhibited (solid 
curves) and non-contact-inhibited (dashed curves) simulations. 
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Fig. 7. Compactness (
cluster hull
C A A= / ) of 128-cell clusters on 200 200! -pixel lattices (~ 
 
400 !m ! 400 !m ) after 5000 MCS (
 
~ 40 h ) for standard chemotaxis, as a function of the adhesion 
between endothelial cells,  J (c,c) . For  J (c,c) < 40  (i.e.  J (c,c) < 2J (c, M ) ) the cells adhere 
without chemotaxis. Insets: Representative configurations after 5000 MCS (~ 40 h). 
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Fig. 8. Compactness (
cluster hull
C A A= / ) of 128-cell clusters on  200 ! 200 -pixel lattices (~ 
 
400 !m ! 400 !m ) after 5000 MCS (
 
~ 40 h ) for standard chemotaxis as a function of absolute 
chemotactic strength, !(c,M ) . Insets: Representative configurations after 5000 MCS (~ 40 h) . 
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Fig. 9. Compactness (
cluster hull
C A A= / ) of 128-cell clusters on 200 200! -lattices (~ 
 
400 !m ! 400 !m ) after 5000 MCS (
 
~ 40 h ) for standard  chemotaxis as a function of the 
saturation of the chemotactic response, s. Insets: representative configurations after 5000 MCS (~ 
40 h). 
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Fig. 10. Compactness (
cluster hull
C A A= / ) of 128-cell clusters (solid curve) on 200 200! -pixel lattices 
(~ 
 
400 !m ! 400 !m ) and 1024-cell clusters (dashed curve) on  400 ! 400 -pixel lattices  (~ 
 
800 !m ! 800 !m ) after 5000 MCS (
 
~ 40 h ) for Savill-Hogeweg chemotaxis as a function of the 
chemoattractant diffusion constant D. Larger diffusion constants have longer diffusion lengths, 
L =
D
!
. Dashed-dotted line shows the compactness of VE-cadherin-inhibited 128-cell clusters. 
Insets: Representative configurations after 5000 MCS (~ 40 h) of the 128-cell clusters (left panels) 
and 1024-cell clusters (right panels; not to scale).  
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Fig. 11. Compactness (
cluster hull
C A A= / ) of 128-cell clusters on  200 ! 200 -pixel lattices (~ 
 
400 !m ! 400 !m ) after 5000 MCS (
 
~ 40 h ) as a function of the cell motility T, for standard 
Savill-Hogeweg [36] extension-retraction chemotaxis (solid line), and for extension-only 
chemotaxis (dashed line). Black lines show the mean over 100 simulations for each T  (with a T-
increment of 10). Dotted grey lines indicate one standard deviation. Insets: Representative 
configurations after 5000 MCS (~ 40 h). 
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Fig. 12. Evolution of the compactness (
cluster hull
C A A= / ) of 256-cell clusters on  500 ! 500 -pixel 
lattices (~ 
 
1000 !m !1000 !m ) vs. time for standard Savill-Hogeweg [36] extension-retraction 
chemotaxis (solid and dashed lines, for 50T =  and 200T =  respectively), and for extension-only 
chemotaxis (dash-dotted line, 200T = ), with only extending pseudopods responding to the 
chemoattractant. Black lines show the mean of 100 simulations. Dotted grey lines mark one 
standard deviation. Insets: Representative configurations after 1000 (~ 8 h) and 5000 MCS (~ 40 h). 
Movies available online. 
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Fig. 13. Cumulative energy differences for standard Savill-Hogeweg [36] extension-retraction 
chemotaxis (solid and dashed lines, for 50T =  and 200T =  respectively), and for extension-only 
chemotaxis (dash-dotted line, 200T = ) as a function of time. Black lines show the mean of 100 
simulations. Dotted grey lines mark one standard deviation. 
 
 
